The pharmaceutical death-ride of dihydroartemisinin.

Malaria Journal
Frans Herwig Jansen

Abstract

In the 2010 second edition of WHO's guidelines for the treatment of malaria, the relatively new fixed dose combination dihydroartemisinin-piperaquine is included as one of the recommended artemisinin combination therapies. However, experimental testing demonstrates that, due to its intrinsic chemical instability, dihydroartemisinin is not suitable to be used in pharmaceutical formulations. In addition, data show that the currently available dihydroartemisinin preparations fail to meet the internationally accepted stability requirements. At a time when many efforts aim to ban counterfeit and substandard drugs from the malaria market, the obvious question rises how WHO and public-private partnerships, such as Medicine for Malaria venture (MMV), can support the production and marketing of anti-malarial drugs that do not even meet the International Pharmacopoeia requirements?

References

Jan 1, 1986·Transactions of the Royal Society of Tropical Medicine and Hygiene
Jan 25, 2008·Die Pharmazie·L DhoogheL Pieters
Jan 29, 2008·Current Medicinal Chemistry·F Herwig Jansen, Shahid A Soomro
Mar 26, 2010·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Paul M O'NeillStephen A Ward
Jun 1, 2010·BMJ : British Medical Journal·Hugh Reyburn

❮ Previous
Next ❯

Citations

Mar 1, 2012·Health Promotion International·Marjorita SormunenHannele Turunen
Sep 5, 2013·The Journal of Antimicrobial Chemotherapy·Alyssa FlobinusNathalie Schnepf
Dec 16, 2010·Future Microbiology·Ingrid B Müller, John E Hyde
Apr 11, 2014·Expert Review of Clinical Pharmacology·Brian Angus
Jul 20, 2012·Expert Opinion on Emerging Drugs·Serena TschanBenjamin Mordmüller
Nov 30, 2013·British Journal of Clinical Pharmacology·Atholl Johnston, David W Holt
Jul 10, 2012·Journal of Pharmaceutical and Biomedical Analysis·Bart M J De SpiegeleerJacques Van Gompel
Mar 10, 2016·The American Journal of Tropical Medicine and Hygiene·Zoe HallHarparkash Kaur
Jan 21, 2014·The Cochrane Database of Systematic Reviews·Babalwa ZaniDavid Sinclair
Mar 10, 2020·ChemMedChem·Clinton G L Veale, Ronel Müller
Apr 24, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Aaron M SamuelsMeghna R Desai
Apr 29, 2020·The American Journal of Tropical Medicine and Hygiene·Meghna R DesaiKim A Lindblade
Jul 18, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yuet WuRichard K Haynes
Sep 24, 2020·Journal of Biomolecular Structure & Dynamics·Ibrahim MalamiImaobong C Etti
Aug 7, 2021·Medicinal Research Reviews·Christopher M WoodleyPaul M O'Neill

❮ Previous
Next ❯

Methods Mentioned

BETA
Assay

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.